06 Oct 2021 | Press Release Horizon Discovery CHOSOURCE Platform Expanding To Include CHO-K1 ADCC+ Expression Cell Line for Development of Therapeutic Antibodies in Oncology, Infectious Disease and Autoimmune Conditions
06 Jul 2021 | News story Horizon as part of an Industry Advisory Committee led by YCharOS, Inc is providing HAP1 cell lines for antibody characterization enabling the research of the broader scientific community
29 Apr 2021 | News story Horizon Discovery and IGM Biosciences sign a multi-license commercial agreement of CHOSOURCE™ for the continued development of novel IgM antibodies
24 Mar 2021 | News story Boan Biotech obtains regulatory approval for their LY-CovMab antibody clinical program using Horizon Discovery’s CHOSOURCE™ CHO-K1 GS Knockout expression platform
04 Feb 2021 | Press Release Horizon Discovery CHOSOURCE Cell Line Supports Trinomab Biotech’s Development of the World-First, Tetanus Toxin mAb Drug for Clinical Trials
04 Aug 2020 | Press Release Horizon Discovery introduces single cell RNAseq-linked CRISPR screening service
29 Jul 2020 | Press Release Horizon Discovery licenses CHOSOURCE platform to TrueBinding for development and commercialization of multiple biotherapeutics
07 Jul 2020 | Press Release Horizon Discovery introduces Cas9 and dCas9-VPR stable cell lines to simplify and accelerate CRISPR gene editing workflows
19 May 2020 | Press Release Rentschler Biopharma licenses Horizon Discovery’s CHOSOURCE platform to complement cell line development offering for difficult-to-express proteins
29 Apr 2020 | Press Release Horizon Discovery extends coverage of OncoSpan reference standards to FFPE and Liquid Biopsy
22 Apr 2020 | Press Release Horizon Discovery CHOSOURCE™ platform supports development of immunotherapy for autoimmune diseases
14 Apr 2020 | Press Release Horizon Discovery offers CHOSOURCE™ platform for COVID-19-related therapeutics and diagnostics
31 Mar 2020 | Press Release Horizon Discovery and Pharmahungary report positive early-stage results for novel micro-RNA therapeutic for ischemic heart diseases
21 Jan 2020 | Press Release Horizon Discovery grants a multi-product use license of its GS knockout CHO K1 cell line to NGM Bio
13 Jan 2020 | Press Release Horizon Discovery signs collaboration and license agreement with Mammoth Biosciences
09 Dec 2019 | Press Release Horizon Discovery introduces predesigned synthetic sgRNAs to streamline CRISPR gene editing workflows
30 Sep 2019 | Press Release Horizon Discovery signs license agreement with Glenmark Pharmaceuticals for GS knockout CHO cell line for manufacture of biotherapeutics
07 Aug 2019 | Press Release Horizon Discovery’s SMARTvector shRNA technology deployed in Celyad’s successful IND filing for next-generation CAR-T cell therapy, CYAD-02
25 Mar 2019 | Press Release Horizon Discovery to collaborate with St George’s University Hospital and EMQN to develop reference material for non-invasive prenatal testing
